01541 宜明昂科-B
公司資料 - 股權變動
日期 股東名稱 披露原因 買入/賣出涉及
的股份數目
每股平均價 持有權益的
股份數目
佔已發行
股本(%)
04/09/2024Halo Biomedical Investment II Limited1213(L)18,000,000(L)5.16
04/09/2024Jiaxing Changxian Enterprise Management L.P. (Limited Partnership) (嘉興昶咸企業管理合夥企業(有限合夥))1711(L)-7,758,630(L)0(L)0.00
04/09/2024Ho Yao1701(L)+4,002,918(L)16,011,675(L)4.59
04/09/2024LAV Corporate V GP, Ltd.1213(L)15,178,770(L)15,178,770(L)4.35
04/09/2024田文志1711(L)+50,269,972(L)118,539,945(L)33.96
04/09/2024上海张江科技创业投资有限公司1701(L)+10,862,055(L)10,862,055(L)7.46
04/09/2024Halo Biomedical Investment I Limited1213(L)18,000,000(L)5.16
04/09/2024Halo Biomedical LP1213(L)18,000,000(L)5.16
04/09/2024LAV GP V, L.P.1213(L)15,178,770(L)15,178,770(L)4.35
04/09/2024Jiaxing Changyu Enterprise Management L.P. (Limited Partnership) (嘉興昶宇企業管理合夥企業(有限合夥))1711(L)-7,419,847(L)0(L)0.00
04/09/2024LAV Biosciences Fund V, L.P.1213(L)15,178,770(L)15,178,770(L)4.35
04/09/2024上海张江科技创业投资有限公司1701(L)+10,862,055(L)10,862,055(L)7.46
04/09/2024上海張科領弋升帆創業投資中心(有限合夥)1113(L)+25,750,000(L)25,750,000(L)7.38
04/09/2024LAV ImmOn Hong Kong Limited1213(L)12,542,805(L)12,542,805(L)3.59
04/09/2024LAV Asset Management (Hong Kong) Limited1213(L)27,721,575(L)27,721,575(L)7.94
04/09/2024于曉勇1113(L)+25,750,000(L)31,304,305(L)8.97
04/09/2024LAV ImmuneOnco Hong Kong Limited1213(L)15,178,770(L)15,178,770(L)4.35
04/09/2024上海張科領弋升帆創業投資中心(有限合夥)1213(L)-25,750,000(L)11,030,390(L)43.87
03/09/2024陈飞1701(L)-7,967,925(L)0(L)0.00
03/09/2024GBA Fund Investment Limited1213(L)13,854,690(L)13,854,690(L)3.97
03/09/2024Shanghai Liyao Investment Management Co., Ltd (上海礼曜投资管理有限公司)1701(L)-7,967,925(L)0(L)0.00
03/09/2024Greater Bay Area Homeland Development Fund (GP) Limited1213(L)13,854,690(L)13,854,690(L)3.97
03/09/2024Greater Bay Area Homeland Investments Limited1213(L)13,854,690(L)13,854,690(L)3.97
03/09/2024GBA Fund Investment Limited1213(L)13,854,690(L)13,854,690(L)3.97
  1   2  
備註: (L) - 長倉:包括 (1) 持有股份;(2) 透過持有、沽出或發行金融合約,有權或有責任購買相關股份。
  (S) - 短倉:包括 (1) 借入股份;(2) 透過持有、沽出或發行金融合約,有權或有責任沽出相關股份。
  (P) - 可供借出的股份
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.